Cargando…
Comparisons of Clinical Outcomes and Prognoses in Patients With Gastroesophageal Junction Adenocarcinoma, by Transthoracic and Transabdominal Hiatal Approaches: A Teaching Hospital Retrospective Cohort Study
To compare the clinical outcomes and prognoses in patients with gastroesophageal junction adenocarcinoma (Siewert type II/III), by transthoracic and transabdominal hiatal approaches. Siewert II/III gastroesophageal junction adenocarcinomas patients (334 cases) underwent different surgical procedures...
Autores principales: | Zhou, Jinzhe, Wang, Hao, Niu, Zhaojian, Chen, Dong, Wang, Dongsheng, Lv, Liang, Li, Yu, Zhang, Jian, Cao, Shougen, Shen, Yi, Zhou, Yanbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058926/ https://www.ncbi.nlm.nih.gov/pubmed/26683954 http://dx.doi.org/10.1097/MD.0000000000002277 |
Ejemplares similares
-
Identification of biomarkers associated with diagnosis and prognosis of gastroesophageal junction adenocarcinoma–a study based on integrated bioinformatics analysis in GEO and TCGA database
por: Song, Danlei, et al.
Publicado: (2020) -
The impact of hiatal hernia on survival outcomes in patients with gastroesophageal junction adenocarcinoma
por: Tanaka, Yuya, et al.
Publicado: (2021) -
Efficacy and safety of ERCP in patients with gastroesophageal varices
por: Hong, Junbo, et al.
Publicado: (2020) -
Tension-free hiatal hernia repair with biological mesh: A real-world experience
por: Cheng, Fahui, et al.
Publicado: (2022) -
Efficacy and safety of anti-PD-1/PD-L1 agents vs chemotherapy in patients with gastric or gastroesophageal junction cancer: a systematic review and meta-analysis
por: Wang, Bi-Cheng, et al.
Publicado: (2019)